Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Feb 9, 18:41 PM 2012 
  NYSE  8081.25  1.73  Index Moved Down   NASDAQ  2927.23  11.37  Index Moved Up 
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for ARDM...
    
Aradigm CorpARDM }
Macroaxis: United States  Stock @ OTCBB    Companies   SEC Records      
    

Aradigm to Present at the 10th Annual BIO Investor Forum on October 26

HAYWARD, Calif., Oct 20, 2011 (BUSINESS WIRE) -- Aradigm Corporation /quotes/zigman/401285 ARDM +3.70% (the "Company") today announced that President and Chief Executive Officer Igor Gonda, Ph.D ...

New CCI Sell Signals - AEXP, ALTH, ALVR, AQLV, ARDM

Retirement Planning - Oct 11, 2011 by Melanie Francine Santos on October 11, 2011 AEXP gained 0.00%, to close at $0.0230 and its overall traded volume was 56,000.00 shares in the last trading session. AEXP opened at $0.02 and is ...

OTCtipReporter.com: Protect Pharmaceutical Corp. (OTCBB: PRTT), Caduceus Software Systems Corp. (OTCBB: CSOC),...

Middle East North Africa Financial Network - Sep 23, 2011 OTCtipReporter.com: Protect Pharmaceutical Corp. PRTT, Caduceus Software Systems Corp. CSOC, Aradigm Corporation ARDM: Sign up for our FREE Stock Picks Today! Sep 23, 2011 (M2 PRESSWIRE via COMTEX ...

Aradigm Presents Additional Analyses Of The Clinical Results From ORBIT-1 And ORBIT-2 Trials Of Inhaled Ciprof...

By Business Wire 09/21/11 - 07:00 AM EDT Aradigm Corporation (OTCBB:ARDM) ("Aradigm") today announced it is presenting data on September 26, 2011, from its Phase 2b studies at the ERS Annual ...

Stocks Report Results: (XIN), (TSE: GTE), (TSE: BDT), (ARDM), (OAS)

Takeover Chatter - Aug 10, 2011 Xinyuan Real Estate Co., Ltd (XIN) reported earnings results for the quarter ended June 2011. Earnings came in at $0.4 per share compared to analyst estimates of $0.22 per share. Earnings were 81 ...

Bay Biz Buzz: Gas prices, stocks, Aradigm, Cost Plus, Infinitech, Pandora

Oakland Tribune - Aug 10, 2011 Monthly Bay Area gas prices rose an average of 2 cents to $3.88 in August, according to reports from AAA Northern California. San Francisco has the highest average prices at $3.94 a gallon and ...

Aradigm Announces Second Quarter 2011 Financial Results

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTC BB: ARDM.OB) (the ?Company?) today announced financial results for the second quarter and six months ended June 30, 2011. Total revenue ...

Aradigm Announces Private Placement for $4.75 Million

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTCBB:ARDM) (the ?Company?) today announced that it has entered into a definitive agreement for the sale of common stock to three existing ...

Aradigm Corporation Announces Private Placement For $4.75 Million

Reuters Key Development - Jul 6, 2011

The Agreement Debate of Aradigm Corp (OTC:ARDM)

HotStocked - Jun 23, 2011 By Petar Ilievski This Wednesday turned out to be an interesting session for Aradigm Corp.(OTC:ARDM, ARDM message board). News at hand, vivid trading activity, and different interpretations of the ...

The Agreement Debate of Aradigm Corp (OTC:ARDM)

HotStocked - Jun 23, 2011 By Petar Ilievski This Wednesday turned out to be an interesting session for Aradigm Corp.(OTC:ARDM, ARDM message board). News at hand, vivid trading activity, and different interpretations of the ...

Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin

Business Wire - Jun 16, 2011 HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTCBB:ARDM) (the ?Company?) today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory ... Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis - News-Medical.net What Traders Are Saying About RNN, CRBC, and ARDM - Small Cap Network Proactive Investors USA & Canada

Aradigm Receives FDA Orphan Drug Designation for Ciprofloxacin for Inhalation in Bronchiectasis

Business Wire - Jun 6, 2011 HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTCBB:ARDM) (the ?Company?) today announced it has received orphan drug designation from the US Food and Drug Administration (FDA) for ... FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasis - News-Medical.net

Aradigm Corporation Receives FDA Orphan Drug Designation For Ciprofloxacin For Inhalation In Bronchiectasis

Reuters Key Development - Jun 6, 2011

New Demand & Necessity Buoy Industry -- Insight on MultiCell Technologies, Inc. and Aradigm Corporat

Several new innovators within the healthcare field have buoyed an influx of new interest to the industry. Combining medical technology with human touch, the healthcare industry diagnoses, treats ...
 Compare To   

Subscribe to Aradigm

    
 Follow Aradigm using RSS feed Add To Reader
Add this feed to your online news reader
Add To Google    Add To Yahoo    Add To MSN
More Gadgets...
    

Aradigm Financial Resources

 
Efficient Frontier
Efficient Frontier
31046  global portfolios
Add positions and diversify yours portfolios

Aradigm 30-Day Moving Performance

    

Macroaxis Total Score 

    
7
Current 30 Days Moving Rating
    
    

Estimated Market Risk

 7.54
  actual daily
 
 13 %
of total potential
 
Market Risk score

Expected Return

 1.25
  actual daily
 
 100 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.23
  actual daily
 
 14 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average   [ change ] 
Increase Risk-Adjusted return of ARDM.OB by adding it to a well-diversified portfolio